Login to Your Account



Favrille's Series C Raises $44M For FavId Pivotal Phase III Trial

By Kim Coghill


Thursday, April 8, 2004
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription